Membranoproliferative glomerulonephritis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
== Overview == | == Overview == | ||
Vaccine against heptatis B and treatment of hepatitis C can be preventive for membranous glomerulopathy. | |||
==Primary Prevention== | |||
* Effective measures for primary prevention of membranous glomerulonephritis include:<ref name="LaiLi1991">{{cite journal|last1=Lai|first1=Kar Neng|last2=Li|first2=Philip K.T.|last3=Lui|first3=Siu Fai|last4=Au|first4=Tak Cheong|last5=Tam|first5=John S.L.|last6=Tong|first6=Kwok Lung|last7=Lai|first7=Fernand Mac-Moune|title=Membranous Nephropathy Related to Hepatitis B Virus in Adults|journal=New England Journal of Medicine|volume=324|issue=21|year=1991|pages=1457–1463|issn=0028-4793|doi=10.1056/NEJM199105233242103}}</ref><ref name="pmid4069286">{{cite journal |vauthors=Gyapay G, Jeney A, Lapis K |title=Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease |journal=Neoplasma |volume=32 |issue=5 |pages=521–8 |date=1985 |pmid=4069286 |doi= |url=}}</ref> | |||
**Vaccine against [[hepatitis B]] can prevent hepatitis B which can lower the risk for membranous glomerulonephritis. | |||
**The treatment of [[hepatitis C]] can prevent the can lower the risk for membranous glomerulonephritis. | |||
==References== | ==References== | ||
Revision as of 20:56, 27 July 2018
Overview
Vaccine against heptatis B and treatment of hepatitis C can be preventive for membranous glomerulopathy.
Primary Prevention
- Effective measures for primary prevention of membranous glomerulonephritis include:[1][2]
- Vaccine against hepatitis B can prevent hepatitis B which can lower the risk for membranous glomerulonephritis.
- The treatment of hepatitis C can prevent the can lower the risk for membranous glomerulonephritis.
References
- ↑ Lai, Kar Neng; Li, Philip K.T.; Lui, Siu Fai; Au, Tak Cheong; Tam, John S.L.; Tong, Kwok Lung; Lai, Fernand Mac-Moune (1991). "Membranous Nephropathy Related to Hepatitis B Virus in Adults". New England Journal of Medicine. 324 (21): 1457–1463. doi:10.1056/NEJM199105233242103. ISSN 0028-4793.
- ↑ Gyapay G, Jeney A, Lapis K (1985). "Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease". Neoplasma. 32 (5): 521–8. PMID 4069286.